Infliximab treatment for refractory Kawasaki syndrome.

Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005 May; 146(5):662-7.

View in: PubMed

subject areas

Adolescent
Antibodies, Monoclonal
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Aspirin
Child
Child, Preschool
Female
Fever
Humans
Immunoglobulins, Intravenous
Infant
Male
Mucocutaneous Lymph Node Syndrome
Retrospective Studies
Treatment Outcome
Tumor Necrosis Factor-alpha

authors with profiles

Marian Melish, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support